Seminar Weekend

2022 Seminar Weekend – topic

Racial inequities in medication use

Two national pandemics – COVID-19 and racism – have highlighted inequities in medication use in the United States. These inequities often translate to poorer health outcomes in communities that already have barriers to optimal health. While the evidence documenting these disparities is abundant, systemic solutions remain elusive. This seminar will focus on #pharmacoequity and how pharmacists can help bring an end to health disparities.

person taking pill


The 28th Pharmaceutical Outcomes and Policy seminar will examine how optimal medication use differs by race and ethnicity and what underlying factors confound this relationship. Experts will discuss imperatives for increasing diversity in clinical trials, removing access barriers, and enhancing data and measures. Finally, industry leaders will share examples of incremental progress made through real-world programs and propose systemic strategies to combat racial inequities in medication use.


Location: Seminar will be held virtually this year – please register below.
Dates: March 5-6, 2022
When: 11 – 1:15 p.m.; 2:30 – 4 p.m. EST


Utibe R. Essien, MD, MPH

Keynote Speaker | "Pursuing pharmacoequity: Race and novel drugs in the US"

Utibe R. Essien, MD, MPH

Assistant Professor of Medicine University of Pittsburgh School of Medicine

Speaker | “Structural racism and pharmacy deserts”

Dima Qato, Pharm.D., MPH, Ph.D.

Senior Fellow, University of Southern California (USC) Schaeffer Center
Hygeia Centennial Chair and Associate Professor, USC School of Pharmacy

SPEAKER | “Bridging the Gap between Social Inequities and Cost Effectiveness Analyses”

Jacquelyn McRae, Pharm.D., M.S.

Director, Policy, Research and Membership

Speaker | “Medicaid policies that promote health equity in the delivery of pharmacy services”

John Coster, Ph.D., R.Ph.

Director, Division of Pharmacy
Center for Medicaid and CHIP
Center for Medicare and Medicaid Services

Speaker | “Increasing diversity in clinical trials and the role of HEOR”

Kim Ribeiro, MLS (ASCP)CM, M.S.

Director, Diversity & Patient Inclusion


Sudeep Karve, Ph.D., M.S., B.Pharm.

Therapeutic Lead, Imbruvica and Solid Tumors

SPEAKER | “A research program examining racial/ethnic disparities in Medicare MTM services”

Junling Wang, Ph.D.

Professor and Vice Chair for Research
Department of Clinical Pharmacy and Translational Science
University of Tennessee College of Pharmacy

SPEAKER | “Advancing health equity through quality measurement”

Micah Cost, Pharm.D., M.S.

CEO, Pharmacy Quality Alliance

Speaker | “Learning from COVID-19: A path towards health equity”

John Allen, Pharm.D. BCPS BCCP, FCCM, FCCP

Associate Dean for Diversity, Inclusion and Health Equity
University of Florida, College of Pharmacy